Summary by Moomoo AI
Ming Kand Pharmaceuticals issued a notice on March 27, 2024 reminding that the stock options first granted under its 2019 Restrictive Stock and Stock Option Incentive Program will enter into the third line option, which will run from June 27, 2023 to May 25, 2024. The Company noted that it is currently in the autonomy phase, but will enter a restricted exercise period from April 1 to April 29, 2024, during which all inductees will not be able to exercise stock options. The Board of Directors of Ming Kand Pharmaceuticals ensures the truthfulness, accuracy and completeness of the contents of the announcement and assumes its legal responsibilities accordingly.